Captrust Financial Advisors »

Outlook Therapeutics shares owned by Captrust Financial Advisors

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Captrust Financial Advisors from 13F filings

Historical chart of Captrust Financial Advisors investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Captrust Financial Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $30k 76k 0.39
2023-09-30 $30k 136k 0.22
2023-06-30 $36k 21k 1.74
2023-03-31 $12k 11k 1.09
2022-09-30 $12k 10k 1.20
2022-06-30 $10k 10k 1.00
2022-03-31 $18k 10k 1.80

More positions owned by Captrust Financial Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Vanguard Value Etf (VTV)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Ishares Ibonds Dec 2024 Term Treasury Etf Etf (IBTE)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard S&p 500 Etf Etf (VOO)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Technology Select Sector Spdr Fund Etf (XLK)
Amazon Stock (AMZN)
Ishares Ibonds Dec 2025 Term Treasury Etf Etf (IBTF)

View all positions for Captrust Financial Advisors

Top funds holding Outlook Therapeutics

Vanguard Group
Rosalind Advisors
Scotia Capital
Millennium Management
Bank of America Corporation
Barclays
Rhumbline Advisers
UBS Group
Ancora Advisors
Jpmorgan Chase & Co
Alliancebernstein
American International
Captrust Financial Advisors
Virtu Financial
Goldman Sachs Group

View all funds holding Outlook Therapeutics